Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for anesthesia induction in gynecological day surgery
ChiCTR2300078737Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Success rate of induction with remimazolam. Started Dec 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300078737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078737.